| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
925.03(M) |
| Last
Volume: |
1,008,943 |
Avg
Vol: |
1,006,166 |
| 52
Week Range: |
$12.64 - $30.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
48,477 |
278,477 |
| Total Buy Value |
$0 |
$0 |
$831,428 |
$6,164,449 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
3 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Robertson Sanford |
Director |
– • – |
2019-12-20 |
4 |
B |
$2.20 |
$932,334 |
D/D |
423,788 |
662,623 |
2.39 |
- |
|
| Robertson Sanford |
Director |
– • – |
2019-12-19 |
4 |
B |
$1.86 |
$141,754 |
D/D |
76,212 |
238,835 |
2.39 |
- |
|
| Schoen Eric |
Chief Financial Officer |
• – – |
2019-12-19 |
4 |
B |
$1.88 |
$9,964 |
D/D |
5,300 |
15,300 |
2.74 |
- |
|
| Barbier Remi |
President and CEO |
• • – |
2019-12-18 |
4/A |
B |
$1.65 |
$4,288 |
I/I |
2,599 |
958,855 |
2.58 |
- |
|
| Barbier Remi |
President and CEO |
• • – |
2019-12-18 |
4 |
B |
$1.65 |
$4,288 |
I/I |
2,599 |
2,599 |
2.58 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-10-03 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-10-03 |
4 |
S |
$1.31 |
$671,738 |
D/D |
(512,660) |
1,651,340 |
|
- |
|
| Robertson Sanford |
Director |
– • – |
2018-09-27 |
4 |
B |
$1.05 |
$39,708 |
D/D |
37,817 |
162,623 |
2.39 |
- |
|
| Robertson Sanford |
Director |
– • – |
2018-09-26 |
4 |
B |
$1.05 |
$32,542 |
D/D |
30,992 |
124,806 |
2.39 |
- |
|
| Robertson Sanford |
Director |
– • – |
2018-09-25 |
4 |
B |
$1.00 |
$21,420 |
D/D |
21,420 |
93,814 |
2.39 |
- |
|
| Robertson Sanford |
Director |
– • – |
2018-09-24 |
4 |
B |
$0.96 |
$9,380 |
D/D |
9,771 |
72,394 |
2.39 |
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-20 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
2,164,000 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-20 |
4 |
S |
$0.91 |
$7,254 |
D/D |
(8,000) |
2,164,000 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-17 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
2,172,000 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-17 |
4 |
S |
$0.95 |
$45,682 |
D/D |
(48,000) |
2,172,000 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-16 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
2,220,000 |
|
- |
|
| Boyd Steven |
10% Owner |
– – • |
2018-08-16 |
4 |
S |
$1.02 |
$1,222,200 |
D/D |
(1,200,000) |
2,220,000 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2016-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
18,386 |
121,479 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2016-04-08 |
4 |
A |
$0.00 |
$0 |
I/I |
25,000 |
126,262 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2016-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
145,300 |
4,515,031 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2016-04-08 |
4 |
A |
$2.16 |
$216,000 |
D/D |
100,000 |
449,893 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2016-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
349,893 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2014-10-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
359,893 |
|
- |
|
| Roddy Peter S |
chief Fianancial Officer |
• – – |
2014-07-14 |
4 |
D |
$5.09 |
$779,025 |
D/D |
(153,050) |
103,093 |
|
- |
|
| Roddy Peter S |
chief Fianancial Officer |
• – – |
2014-07-14 |
4 |
OE |
$4.54 |
$779,023 |
D/D |
171,591 |
256,143 |
|
- |
|
83 Records found
|
|
Page 3 of 4 |
|
|
1.56 (7.24%) 
